JP2005538088A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538088A5
JP2005538088A5 JP2004522603A JP2004522603A JP2005538088A5 JP 2005538088 A5 JP2005538088 A5 JP 2005538088A5 JP 2004522603 A JP2004522603 A JP 2004522603A JP 2004522603 A JP2004522603 A JP 2004522603A JP 2005538088 A5 JP2005538088 A5 JP 2005538088A5
Authority
JP
Japan
Prior art keywords
formula
defined above
compound
symbols
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004522603A
Other languages
English (en)
Japanese (ja)
Other versions
JP4860151B2 (ja
JP2005538088A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/002879 external-priority patent/WO2004009560A1/en
Publication of JP2005538088A publication Critical patent/JP2005538088A/ja
Publication of JP2005538088A5 publication Critical patent/JP2005538088A5/ja
Application granted granted Critical
Publication of JP4860151B2 publication Critical patent/JP4860151B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004522603A 2002-07-22 2003-07-21 新規な生物活性分子 Expired - Fee Related JP4860151B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN548MA2002 2002-07-22
IN548/MAS/2002 2002-07-22
PCT/IB2003/002879 WO2004009560A1 (en) 2002-07-22 2003-07-21 Novel bio-active molecules

Publications (3)

Publication Number Publication Date
JP2005538088A JP2005538088A (ja) 2005-12-15
JP2005538088A5 true JP2005538088A5 (https=) 2010-07-15
JP4860151B2 JP4860151B2 (ja) 2012-01-25

Family

ID=37775275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004522603A Expired - Fee Related JP4860151B2 (ja) 2002-07-22 2003-07-21 新規な生物活性分子

Country Status (9)

Country Link
US (1) US7317014B2 (https=)
EP (1) EP1542978B1 (https=)
JP (1) JP4860151B2 (https=)
AT (1) ATE505462T1 (https=)
AU (1) AU2003249484A1 (https=)
CA (1) CA2492342C (https=)
DE (1) DE60336735D1 (https=)
ES (1) ES2365011T3 (https=)
WO (1) WO2004009560A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006510597A (ja) * 2002-09-27 2006-03-30 メルク エンド カムパニー インコーポレーテッド 置換ピリミジン類
TW200637556A (en) * 2005-01-31 2006-11-01 Basf Ag Substituted 5-phenyl pyrimidines I in therapy
ES2524922T3 (es) 2005-05-10 2014-12-15 Intermune, Inc. Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
US7452892B2 (en) 2005-06-17 2008-11-18 Bristol-Myers Squibb Company Triazolopyrimidine cannabinoid receptor 1 antagonists
CA2626789A1 (en) 2005-10-21 2007-04-26 Exelixis, Inc. Pyrimidinones as casein kinase ii (ck2) modulators
US7863446B2 (en) * 2006-01-19 2011-01-04 Orchid Research Laboratories Limited Heterocycles
AU2006335967B2 (en) * 2006-01-19 2012-01-19 Orchid Chemicals & Pharmaceuticals Limited Novel heterocycles
DE102006054205A1 (de) * 2006-11-15 2008-05-29 Rheinische Friedrich-Wilhelms Universität Verwendung von Cytohesin-Inhibitoren zur chemischen Induktion von Langlebigkeit
MX336946B (es) * 2008-02-01 2016-02-08 Orchid Res Lab Ltd Heterociclos novedosos.
JP5507445B2 (ja) * 2008-04-16 2014-05-28 株式会社林原 2−アミノフェノール又はその誘導体を有効成分とする骨形成促進剤
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
WO2011038204A1 (en) 2009-09-25 2011-03-31 N30 Pharmaceuticals, Llc Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
EP2618666A4 (en) 2010-09-24 2014-04-16 N30 Pharmaceuticals Inc NEW DIHYDROPYRIMIDIN-2 (1H) -ON COMPOUNDS AS NEUROKININ-3 RECEPTOR ANTAGONISTS
CZ305457B6 (cs) 2011-02-28 2015-09-30 Ústav organické chemie a biochemie, Akademie věd ČR v. v. i. Pyrimidinové sloučeniny inhibující tvorbu oxidu dusnatého a prostaglandinu E2, způsob výroby a použití
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
US20200270216A1 (en) * 2017-09-15 2020-08-27 Tina Bilousova Compositions and methods for inhibiting n-smase2
TW202321229A (zh) 2021-08-18 2023-06-01 美商富曼西公司 殺真菌的取代的雜環化合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2602794A (en) * 1952-07-08 Process for preparation of x-amino-s
BE759176A (fr) * 1969-11-20 1971-05-19 Sandoz Sa Derives de la pyrimidine, leur preparation et medicaments contenant cesderives
DE2142317A1 (de) 1971-08-24 1973-03-01 Bayer Ag Hypnotisches mittel
US4438117A (en) * 1980-09-03 1984-03-20 E. I. Du Pont De Nemours And Company 2-Substituted thio-4,5-diarylpyrimidines
US4500533A (en) * 1983-06-22 1985-02-19 Eli Lilly And Company 2,4,5-Triaryl pyrimidines and a method of treating pain, fever, thrombosis, inflammation and arthritis
DE3605002A1 (de) * 1986-02-18 1987-08-20 Bayer Ag Phosphorsaeureester
GB8909560D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Chemical compounds
WO1992002513A1 (en) * 1990-08-06 1992-02-20 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compounds
US5486534A (en) * 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
US6410729B1 (en) * 1996-12-05 2002-06-25 Amgen Inc. Substituted pyrimidine compounds and methods of use
US6096753A (en) * 1996-12-05 2000-08-01 Amgen Inc. Substituted pyrimidinone and pyridone compounds and methods of use
JP4064671B2 (ja) * 2000-02-25 2008-03-19 エフ.ホフマン−ラ ロシュ アーゲー アデノシン受容体モジュレーター
KR100608414B1 (ko) * 2002-02-13 2006-08-02 에프. 호프만-라 로슈 아게 신규한 피리딘- 및 피리미딘-유도체
AU2003216585A1 (en) * 2002-04-10 2003-10-20 Orchid Chemicals And Pharmaceuticals Limited Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases

Similar Documents

Publication Publication Date Title
JP2005538088A5 (https=)
JP2008505224A5 (https=)
JP2009533369A5 (https=)
JP2010501516A5 (https=)
JP2006520339A5 (https=)
RU2007116248A (ru) Способ получения производных 3-аминопиперидина
JP2011500769A5 (https=)
JP2005533804A5 (https=)
JP2019048806A5 (https=)
JP2007500753A5 (https=)
JP2001261662A5 (https=)
JP2009527517A5 (https=)
JP2016188255A5 (https=)
EP1849788A8 (en) Organosilicon compound
IL188716A0 (en) Method for preparing 4??-amino-4'-dimethyl-4-
JP2005509682A5 (https=)
JP2008247919A5 (https=)
ATE389631T1 (de) Verfahren zur herstellung von fexofenadinen
JP2010132661A5 (https=)
RU2003114411A (ru) Способ получения замещенного анилинового соединения
JP2007048462A5 (https=)
TW200722434A (en) Stereoselective synthesis of β-nucleosides
JP2005536557A5 (https=)
JP2006325520A5 (https=)
ATE528358T1 (de) Verfahren zur herstellung einer azoverbindung